Table 1. Main published works in 2020 regarding drug candidates tested against SARS-CoV, MERS-CoV and SARS-CoV-2, in terms of drug, target binding, type of assays and its traditional uses.
Drug | Target | Assays | Usual treatment | Ref. |
---|---|---|---|---|
Arbidol | Binds to hemagglutinin | In vitro | Influenza, arboviruses | [47] |
Atazanavir | Inhibition of the 3CLPRO | In silico, in vitro | HIV | [48] |
Chloroquine | Immunomodulatory effects, increase endosomal pH required for virus | In vitro, clinical trial | Malaria | [49,50] |
Dactinomycin† | RNA synthesis inhibitor | In silico | Cancer | [51] |
Darunavir | Protease inhibitor | In silico | HIV | [48,52] |
Dolutegravir | Protease inhibitor | In silico | HIV | [42] |
Efavirenz | Inhibition of the 3CLPRO | In silico | HIV | [42] |
Emetine | Inhibits the replication of RNA viruses | In vitro | Amoebiasis | [53] |
Emodin | Blocked the interaction between the spike and ACE2 | In silico, in vitro | Cancer | [51] |
Favipiravir | RNA-dependent RNA polymerase (RdRp) inhibitor | In vitro, clinical trial | Influenza | [49,54] |
Galidesivir | Bind RdRp | In silico | Hepatitis C virus (HCV) | [55] |
Hydroxychloroquine | Immunomodulatory effects, increase endosomal pH required for virus | In vitro, clinical trial | Malaria | [50,56] |
Ivermectin | In vitro | Parasites | [57] | |
Lopinavir-ritonavir | inhibition of the 3CLPRO | In vitro, clinical trial | HIV | [58] |
Melatonin‡ | regulates ACE2 expression | In silico | Several including insomnia | [45] |
Mercaptopurine | Inhibition Papain-like protease | In silico, in vitro | Cancer and auto-immune diseases | [45] |
Remdesivir | Inhibition the RdRp/Seems to inhibit of the 3CLPRO | In silico, in vitro, in vivo | HIV/Ebola | [42,43,46,49] |
Ribavirin | Inhibits RdRp | In silico | HCV, respiratory syncytial virus (RSV) | [59] |
Saquinavir | inhibition of the 3CLPRO | In silico | HIV | [52] |
Sirolimus† | Inhibitor of mTOR | In silico | Antifungal and cancer | [45] |
Sofosbuvir | Bind RdRp | In silico | HCV | [55,59] |
Tenofovir | Bind RdRp | In silico | HIV | [49] |
Tirolone | Inducer of interferon | In vitro | Influenza, hepatitis, viral encephalitis and others | [60,61] |
Toremifene | Destabilizing the virus membrane glycoprotein | In silico, in vitro | Cancer | [45] |
Sirolimus and dactinomycin.
Melatonin and mercaptopurine.